These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8990347)

  • 1. Targeting of antihapten antibodies to activated T cells via an IL-2-hapten conjugate prolongs cardiac graft survival.
    Lussow AR; Fanget L; Gao L; Block M; Buelow R; Pouletty P
    Transplantation; 1996 Dec; 62(12):1703-8. PubMed ID: 8990347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo.
    Lussow AR; Buelow R; Fanget L; Peretto S; Gao L; Pouletty P
    J Immunother Emphasis Tumor Immunol; 1996 Jul; 19(4):257-65. PubMed ID: 8877720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
    Lussow AR; Fanget L; Gao L; Buelow R; Pouletty P
    Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277
    [No Abstract]   [Full Text] [Related]  

  • 4. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carrier and hapten array on the production of anti-hapten antibodies analyzed by two-dimensional affinity electrophoresis.
    Wang P; Nakamura K
    Electrophoresis; 1998 Jun; 19(8-9):1506-10. PubMed ID: 9694303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to the HLA class I alpha 3 domain inhibits T cell activation and prolongs cardiac allograft survival in HLA-transgenic mice.
    Woo J; Cornejo MC; Gao L; Taurog JD; Hammer RE; Buelow R
    Transpl Immunol; 1997 Jun; 5(2):112-21. PubMed ID: 9269033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody.
    Pearson TC; Bushell AR; Darby CR; West LJ; Morris PJ; Wood KJ
    Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
    Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
    Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells.
    Lu Y; Sega E; Low PS
    Int J Cancer; 2005 Sep; 116(5):710-9. PubMed ID: 15828051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
    Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.